Dr. Ghorab is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7200 Cambridge St
Fl 7
Houston, TX 77030Phone+1 713-798-1000
Education & Training
Georgia Southwestern State UniversityMaster of Business Administration (MBA), Business Administration and Management, 2022 - 2024- American Public UniversityMaster of Public Health (MPH), Public Health, 2019 - 2024
- Cairo University School of Medicine MS Degree, Clinical Oncology, 2012 - 2015
- Cairo University Hospital Residency, 2012 - 2015
Cairo University School of MedicineClass of 2012, MD
Certifications & Licensure
TX State Medical License 2023 - 2026
FL State Medical License 2021 - 2025- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 86 citationsLong-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib.Preetesh Jain, Rashmi Kanagal-Shamanna, Shaojun Zhang, Makhdum Ahmed, Ahmad Ghorab
British Journal of Haematology. 2018-11-01 - 102 citationsPrognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients.Preetesh Jain, Hagop M. Kantarjian, Ahmad Ghorab, Koji Sasaki, Elias J. Jabbour
Cancer. 2017-11-15 - 2 citationsClinical outcome of myelodysplastic syndrome progressing on hypomethylating agents with evolving frontline therapies: continued challenges and unmet needs.Ahmad Ghorab, Aref Al-Kali, Michelle Elliot, Naseema Gangat, Hasan Alkhateeb
Blood Cancer Journal. 2022-06-24
Lectures
- Clinical and Genomic Characteristics in De Novo Blastoid/Pleomorphic (dnMCL) and Transformed Blastoid/Pleomorphic (t-MCL) Mantle Cell Lymphoma (MCL) in the Ibrutinib E...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Impact of numerical variation, allele burden and mutation length on outcomes in acute myeloid leukemia with fms-like tyrosine kinase receptor-3 internal tandem duplica...2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Professional Memberships
- Member
- Member
- Member
- Member
- European Society of Medical Oncology (ESMO)Member
- Arab Medical Association Against Cancer (AMAAC)Member
- MD Anderson Alumni AssociationMember
- Society of Hematologic Oncology (SOHO)Member
Other Languages
- Arabic
External Links
- Ahmad Ghorab, MD, MSchttps://www.linkedin.com/in/ahmad-ghorab-md-msc/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
